ArticleMedicine and pharmacy reports2020
Depression, anxiety and stress among patients with hematological malignancies and the association with quality of life: a cross-sectional study.
Article in Medicine and pharmacy reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.
- A systematic review of coping skill interventions to reduce anxiety and depressive symptoms among adults with hematologic malignancies.European journal of oncology nursing : the official journal of European Oncology Nursing Society · 2022Pooled it
- The effect of depression, anxiety and stress levels on the quality of life and self-care agency of patients with gynecological cancer: cross-sectional study.BMC women's health · 2026Article
- Associations between serum neuropeptide Y levels and anxiety, depression, and quality of life in Chinese patients with primary glaucoma.BMC ophthalmology · 2025Article
- Development of a modular patient-reported outcome and experience measure on patient needs and benefits in CLL (PBI-CLL).Journal of patient-reported outcomes · 2025Article
- Psychometric Properties of the Depression Anxiety Stress Scales (DASS-42 and DASS-21) in Patients with Hematologic Malignancies.Journal of clinical medicine · 2025Article
- Impact of stress and coping strategies on quality of life in hematological malignancies: A cross-sectional study.PloS one · 2025Article
- Disease-specific complaints among multiple myeloma patients treated with chemotherapy, autotransplantation and supportive therapy in Poland: a cross-sectional study.Scientific reports · 2024Article
- Quality of Life and Symptoms of Hospitalized Hematological Cancer Patients.Current oncology (Toronto, Ont.) · 2024Article
- Coping and Perception of Prognosis in Patients With Indolent Non-Hodgkin's Lymphoma.The oncologist · 2024Article
- The remodeling of metabolic brain pattern in patients with extracranial diffuse large B-cell lymphoma.EJNMMI research · 2023Article
- Mental health needs in cancer - a call for change.Future healthcare journal · 2023Article
- Psychological distress and health-related quality of life among women with breast cancer: a descriptive cross-sectional study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022Article
- A cross-sectional study evaluating health-related quality of life of Chinese pediatric patients with hematological malignancies using EQ-5D-Y.Frontiers in public health · 2022Article
- Chaigui granule exerts anti-depressant effects by regulating the synthesis of Estradiol and the downstream of CYP19A1-E2-ERKs signaling pathway in CUMS-induced depressed rats.Frontiers in pharmacology · 2022Article
- Assessment of depression, anxiety and stress levels in the Ecuadorian general population during social isolation due to the COVID-19 outbreak: a cross-sectional study.BMC psychiatry · 2021Article
- Unique insights from ClinicalTrials.gov by mining protein mutations and RSids in addition to applying the Human Phenotype Ontology.PloS one · 2020Article
- Effects of an Interdisciplinary Integrative Oncology Group-Based Program to Strengthen Resilience and Improve Quality of Life in Cancer Patients: Results of a Prospective Longitudinal Single-Center Study.Integrative cancer therapiesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo evaluate psychological distress and quality of life of patients with hematological malignancies, as well as to identify the prognostic factors that aggravate their condition.
methodsA cross-sectional, descriptive study including 87 patients with Hematological Malignancies was conducted. Data were collected with an anonymous questionnaire consisted by A) a sheet with socio-demographic characteristics, B) the Depression, Stress and Stress Scale (DASS21), and C) World Health Organization Life Quality Scale (WHOQOL - BREF30). The processing and statistical analysis of the empirical material of the research were done using the SPSS (Statistical Package for Social Science) 22.0.
resultsThe results showed that the age of the sample averaged 71.22 years (SD = 8.71). Regarding their marital status, single mothers were 9.2%, married 62.1%. With regard to disease-related features, 28.7% of patients had Hodgkin's Lymphoma, 27.6% Chronic Lymphocytic Leukemia, 27.6% MDL and 16.1% of patients had myelodysplastic syndrome Multiple myeloma. In the investigation of the relationship between the Mental health Scale and the Quality of Life, negative correlations of Depression, Stress, Stress and the total DAS Scale with all dimensions of Patient Quality of Life were found.
conclusionsHigher levels of psychological distress and poor mental health are associated with a low level of quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.